ERBB2 and breast cancer: MYC dysregulation induces genome instability such as CIN18, 45 may explain why MYC amplification is strongly linked to copy number aberrations of other oncogenes, such as HER2 amplification in 40% of breast cancer and 5% of gastric cancer cases.19, 46